Inflectis Bioscience

Small Molecules to treat misfolding protein disorders such as Charcot-Marie-Tooth, Retinitis Pigmentosa

placeNantes, Pays De La Loire, France calendar_todayFounded 2013 groups8 employees language inflectisbioscience.com

Innovation

6 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 475 times.

YearFilings
20141
20151
20163
20174
20183
20191
20204
20213
20221
20242
20251
20261

Investor mix

3 investors on record; lead investors include Credit Mutuel Equity.

Investor typeCountShare
Venture capital133%
Private equity267%
Coming soon